Innovation in Reproductive
and Women's Health
Begins with Listening
-
Shaping the Future of Reproductive and Women’s Health
-
Bio-Rad Molecular Diagnostics Grant Program
Bio-Rad is partnering with physicians and research scientists studying molecular biomarkers for key reproductive and women’s health applications. Innovative technologies such as ddPCR (droplet digital PCR) that enable simple workflows for the sensitive and rapid detection of molecular biomarkers, are well positioned to address existing and novel applications in reproductive and women’s health.
As of March 1, 2025, we have reached an unprecedented number of applications and are no longer accepting new submissions.
-
ddPCR for Molecular Biomarkers
Our simple and reliable Droplet Digital PCR (ddPCR) platform has already led to innovations in oncology, infectious disease and genetics. While next generation sequencing (NGS) is useful for biomarker discovery, for the routine screening of known biomarkers, ddPCR often provides a more rapid, sensitive, and cost-effective approach.
Learn about ddPCR -
Why Use ddPCR?
- Flexible and simple to adapt
- Low intra- and inter-assay variance
- Absolute quantification
- Simple multiplexing
- Sensitive – detect rare targets in complex backgrounds
-
"We want to give researchers the tools and support to develop biomarkers that will really make a difference to patients' lives."
Nargol Faravashi
Sr. Dir. Market Strategy, Molecular DiagnosticsBio-Rad Laboratories Inc.
- Follow and share:
